LENALIDOMIDE Side Effects

7006527-0 | Fatigue, Pleural Effusion, Pyrexia
on Sep 21, 2010 Male patient from UNITED STATES , weighting 278.9 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and was treated with Lenalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, pleural effusion, pyrexia. Lenalidomide dosage: 25 Mg Once Daily Po. During the same period patient was treated with FISH OIL (View Fish Oil Review and Fish Oil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMBIEN (View Ambien Review and Ambien Label ), MULTIPLE VITAMIN (View Multiple Vitamin Review and Multiple Vitamin Label ). Patient was hospitalized.

7005022-2 | Dermatitis Exfoliative
Patient was taking Lenalidomide (View Usage). Patient had the following side effects: dermatitis exfoliative on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 218.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), prophylaxis and. Lenalidomide dosage: 10 Mg Every Day Po. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (1 Tab Bid Po) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ). Patient was hospitalized.

6992272-4 | Anxiety, Coronary Artery Occlusion, Myocardial Ischaemia, Stress
Adverse event was reported on Sep 14, 2010 by a Female patient taking Lenalidomide (View Usage) (Dosage: 20mg Qday Po, 21/28 Days) was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Location: UNITED STATES , weighting 191.8 lb, After Lenalidomide was administered, patient had the following side effects: anxiety (What is anxiety?), coronary artery occlusion, myocardial ischaemia, stress (What is stress?). During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), RESTORIL (View Restoril Review and Restoril Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), PAXIL (View Paxil Review and Paxil Label ). Patient was hospitalized.

6983422-4 | Malignant Neoplasm Progression, Mental Status Changes
on Sep 14, 2010 Male patient from UNITED STATES , weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Lenalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: malignant neoplasm progression, mental status changes. Lenalidomide dosage: 50mg Qd D1-28 Po. During the same period patient was treated with AZACITIDINE (25mg/m2 D1-5 Iv) (View Azacitidine Review and Azacitidine Label ).


6983421-2 | Febrile Neutropenia, Osteoarthritis, Pneumonia, Renal Failure Acute, Renal Impairment, Unresponsive To Stimuli
on Sep 14, 2010 Female patient from UNITED STATES , weighting 90.10 lb, was diagnosed with acute myeloid leukaemia and was treated with Lenalidomide (View Usage). Patient had the following side effects: febrile neutropenia, osteoarthritis (What is osteoarthritis?), pneumonia (What is pneumonia?), renal failure acute, renal impairment, unresponsive to stimuli. Lenalidomide dosage: 50 Mg Qd D1-28 Po. During the same period patient was treated with AZACITIDINE (25mg/m2 D1-5 Iv) (View Azacitidine Review and Azacitidine Label ). Patient was hospitalized.

6977307-7 | Arthralgia, Pain In Extremity, Pseudomonal Sepsis
Patient was taking Lenalidomide (View Usage). After Lenalidomide was administered, patient had the following side effects: arthralgia, pain in extremity, pseudomonal sepsis on Sep 06, 2010 from AUSTRALIA Additional patient health information: Female patient , weighting 103.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), hypertension, thrombosis prophylaxis and. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), PRESOLOL (View Presolol Review and Presolol Label ), DIFFLAM (View Difflam Review and Difflam Label ), SLOW K (View Slow-k Review and Slow-k Label ), ASPIRINE (View Aspirine Review and Aspirine Label ), MICARDIS (View Micardis Review and Micardis Label ). Patient was hospitalized.

6973524-0 |
Adverse event was reported on Sep 01, 2010 by a Male patient taking Lenalidomide (View Usage) (Dosage: ) was diagnosed with oedema peripheral, constipation (What is constipation?), dyslipidaemia and. Location: CANADA , weighting 192.5 lb, . During the same period patient was treated with CALCIUM AND VIT D (View Calcium And Vit D Review and Calcium And Vit D Label ), OMEGA 3 ACID ETHYL ESTERS (400-200mg) (View Omega-3-acid Ethyl Esters Review and Omega-3-acid Ethyl Esters Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), LASIX (View Lasix Review and Lasix Label ), COLACE (View Colace Review and Colace Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6973403-9 | Hypoalbuminaemia
on Aug 30, 2010 Male patient from FRANCE , weighting 154.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), epilepsy (What is epilepsy?) and was treated with Lenalidomide (View Usage). Patient had the following side effects: hypoalbuminaemia. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), KEPPRA (View Keppra Review and Keppra Label ), TEMERIT (View Temerit Review and Temerit Label ), PRETERAX (View Preterax Review and Preterax Label ), HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ). Patient was hospitalized.

6971879-4 | Blood Culture Positive, Dysuria, Pyrexia, Serratia Infection, Staphylococcal Infection, Tachypnoea, Tremor, Urinary Tract Infection
on Sep 08, 2010 Male patient from UNITED STATES , 77 years of age, weighting 195.3 lb, was treated with Lenalidomide (View Usage). After Lenalidomide was administered, patient had the following side effects: blood culture positive, dysuria, pyrexia, serratia infection, staphylococcal infection (What is staphylococcal infection?), tachypnoea, tremor, urinary tract infection (What is urinary tract infection?). Lenalidomide dosage: 20 Mg Po Daily. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LASIX (View Lasix Review and Lasix Label ), PRANDIN (View Prandin Review and Prandin Label ), ZOCOR (View Zocor Review and Zocor Label ), XCL (View Xcl Review and Xcl Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6970105-X | Diarrhoea, Ileus Paralytic
Patient was taking Lenalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, ileus paralytic on Aug 27, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , weighting 128.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), thrombosis prophylaxis, gastritis prophylaxis and. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ASPARIN (View Asparin Review and Asparin Label ), CURAN (View Curan Review and Curan Label ). Patient was hospitalized.

6968365-4 | Lower Respiratory Tract Infection, Respiratory Failure
Adverse event was reported on Sep 01, 2010 by a Female patient taking Lenalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), antiviral prophylaxis, antifungal prophylaxis, gastritis prophylaxis, thrombosis prophylaxis and. Location: UNITED KINGDOM , weighting 83.11 lb, Patient had the following side effects: lower respiratory tract infection, respiratory failure. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), COTRIM (View Cotrim Review and Cotrim Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRINE (View Aspirine Review and Aspirine Label ).

6960212-X | Lower Respiratory Tract Infection, Pulmonary Embolism, Respiratory Failure
on Aug 26, 2010 Female patient from UNITED KINGDOM , weighting 83.11 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), antiviral prophylaxis, antifungal prophylaxis, gastritis prophylaxis, thrombosis prophylaxis and was treated with Lenalidomide (View Usage). After Lenalidomide was administered, patient had the following side effects: lower respiratory tract infection, pulmonary embolism (What is pulmonary embolism?), respiratory failure. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), COTRIM (View Cotrim Review and Cotrim Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRINE (View Aspirine Review and Aspirine Label ).

6959246-0 | Cholecystitis, Gastric Cancer
on Aug 20, 2010 Male patient from JAPAN , weighting 147.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), pneumonia (What is pneumonia?), dry skin, muscle spasms, constipation (What is constipation?), headache (What is headache?), pyrexia, deep vein thrombosis (What is deep vein thrombosis?) and was treated with Lenalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis, gastric cancer. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LEVOFLOXACIN HYDRATE (View Levofloxacin Hydrate Review and Levofloxacin Hydrate Label ), UREA (Optimal Dose) (View Urea Review and Urea Label ), KETOPROFEN (Optimal Dose) (View Ketoprofen Review and Ketoprofen Label ), PANTETHINE (View Pantethine Review and Pantethine Label ), LOXOPROFEN SODIUM HYDRATE (View Loxoprofen Sodium Hydrate Review and Loxoprofen Sodium Hydrate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6958438-4 | Osteitis
Patient was taking Lenalidomide (View Usage). Patient had the following side effects: osteitis on Aug 18, 2010 from SWEDEN Additional patient health information: Female patient , weighting 218.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), hypertension and. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LOSARTAN/HYDROCHLOORTHIAZIDE (50/12.5mg) (View Losartan/hydrochloorthiazide Review and Losartan/hydrochloorthiazide Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6956029-2 | Septic Shock
Adverse event was reported on Aug 24, 2010 by a Male patient taking Lenalidomide (View Usage) (Dosage: ) was diagnosed with mantle cell lymphoma and. Location: ISRAEL , weighting 160.9 lb, After Lenalidomide was administered, patient had the following side effects: septic shock. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ).

6945547-9 | Intestinal Obstruction, Urinary Retention
on Aug 17, 2010 Male patient from FRANCE , weighting 176.4 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), thrombosis prophylaxis, hypothyroidism and was treated with Lenalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal obstruction, urinary retention. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CLASTOBAN (View Clastoban Review and Clastoban Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LERCAN (View Lercan Review and Lercan Label ), CRESTOR (View Crestor Review and Crestor Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6944744-6 | Pharyngeal Inflammation
on Aug 16, 2010 Male patient from RUSSIAN FEDERATION , weighting 220.5 lb, was diagnosed with mantle cell lymphoma, arrhythmia prophylaxis, thrombosis prophylaxis, parkinson's disease (What is parkinson's disease?), hypothyroidism and was treated with Lenalidomide (View Usage). Patient had the following side effects: pharyngeal inflammation. Lenalidomide dosage: . During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CONCOR (View Concor Review and Concor Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), PIRIBEDIL (View Piribedil Review and Piribedil Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

6938565-8 | Vomiting, Weight Decreased
Patient was taking Lenalidomide (View Usage). After Lenalidomide was administered, patient had the following side effects: vomiting, weight decreased on Aug 11, 2010 from AUSTRIA Additional patient health information: Male patient , weighting 143.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), hypercholesterolaemia, hypertension, prophylaxis and. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), CONCOR (View Concor Review and Concor Label ). Patient was hospitalized.

6933044-6 | Nephrolithiasis, Pancytopenia, Renal Failure Acute
Adverse event was reported on Aug 18, 2010 by a Male patient taking Lenalidomide (View Usage) (Dosage: 25 Mg Every Day Po) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 64 years of age, weighting 202.8 lb, Patient experienced the following unwanted or unexpected effects: nephrolithiasis, pancytopenia, renal failure acute. Patient was hospitalized.

6931784-6 | Dyspnoea, Hyperbilirubinaemia, Malignant Neoplasm Progression, Oedema
on Aug 17, 2010 Male patient from BELGIUM , weighting 264.6 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Lenalidomide (View Usage). Patient had the following side effects: dyspnoea, hyperbilirubinaemia, malignant neoplasm progression, oedema. Lenalidomide dosage: . During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ). Patient was hospitalized.

6929612-8 | Diarrhoea, Ileus Paralytic
on Aug 05, 2010 Male patient from KOREA, REPUBLIC OF , weighting 128.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), thrombosis prophylaxis, gastritis prophylaxis and was treated with Lenalidomide (View Usage). After Lenalidomide was administered, patient had the following side effects: diarrhoea, ileus paralytic. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ASPARIN (View Asparin Review and Asparin Label ), CURAN (View Curan Review and Curan Label ), AMBROXOL (View Ambroxol Review and Ambroxol Label ). Patient was hospitalized.

6927608-3 |
Patient was taking Lenalidomide (View Usage). on Aug 10, 2010 from CANADA Additional patient health information: Male patient , weighting 192.5 lb, was diagnosed with oedema peripheral, constipation (What is constipation?), dyslipidaemia and. Lenalidomide dosage: . During the same period patient was treated with CALCIUM AND VIT D (View Calcium And Vit D Review and Calcium And Vit D Label ), OMEGA 3 ACID ETHYL ESTERS (400-200mg) (View Omega-3-acid Ethyl Esters Review and Omega-3-acid Ethyl Esters Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), LASIX (View Lasix Review and Lasix Label ), COLACE (View Colace Review and Colace Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6927559-4 | Anaemia
Adverse event was reported on Aug 10, 2010 by a Female patient taking Lenalidomide (View Usage) (Dosage: ) was diagnosed with mantle cell lymphoma and. Location: FRANCE , weighting 143.3 lb, Patient had the following side effects: anaemia.

6927521-1 | Hyperhidrosis, Loss Of Consciousness, Malaise, Nausea, Urinary Incontinence
on Aug 04, 2010 Male patient from FRANCE , weighting 183.0 lb, was diagnosed with mantle cell lymphoma refractory and was treated with Lenalidomide (View Usage). After Lenalidomide was administered, patient had the following side effects: hyperhidrosis, loss of consciousness, malaise, nausea (What is nausea?), urinary incontinence (What is urinary incontinence?). Lenalidomide dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AVK (View Avk Review and Avk Label ), PREVISCAN (View Previscan Review and Previscan Label ), DIFFU K (View Diffu K Review and Diffu K Label ), MORPAL 20 (View Morpal 20 Review and Morpal 20 Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ). Patient was hospitalized.

6926259-4 | International Normalised Ratio Increased
on Feb 25, 2010 Female patient from FRANCE , weighting 94.80 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), hypertension, thrombosis prophylaxis, infection prophylaxis and was treated with Lenalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), AMLODINE (View Amlodine Review and Amlodine Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), PREVISCAN (View Previscan Review and Previscan Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ).

6924312-2 | Neutrophil Count Decreased
Patient was taking Lenalidomide (View Usage). Patient had the following side effects: neutrophil count decreased on Aug 11, 2010 from UNITED STATES Additional patient health information: Female patient , 55 years of age, weighting 209.9 lb, was diagnosed with lymphoma (What is lymphoma?) and. Lenalidomide dosage: 15 Mg Daily Oral.

6924311-0 | Neutrophil Count Decreased
Adverse event was reported on Aug 11, 2010 by a Female patient taking Lenalidomide (View Usage) (Dosage: 15 Mg Daily Oral) was diagnosed with lymphoma (What is lymphoma?) and. Location: UNITED STATES , 56 years of age, weighting 209.9 lb, After Lenalidomide was administered, patient had the following side effects: neutrophil count decreased.

6921129-X | Cytomegalovirus Chorioretinitis, Leukopenia, Neutropenia, Ocular Vasculitis, Thrombocytopenia
on Aug 06, 2010 Male patient from FRANCE , weighting 125.7 lb, was diagnosed with t-cell lymphoma, eye infection (What is eye infection?) and was treated with Lenalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus chorioretinitis, leukopenia, neutropenia, ocular vasculitis, thrombocytopenia. Lenalidomide dosage: . During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

6919494-2 | Gastric Cancer
on Jul 30, 2010 Male patient from JAPAN , weighting 147.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), cholecystitis, pneumonia (What is pneumonia?), dry skin, constipation (What is constipation?) and was treated with Lenalidomide (View Usage). Patient had the following side effects: gastric cancer. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ANTIBIOTIC (View Antibiotic Review and Antibiotic Label ), SUCRALFATE HYDRATE (View Sucralfate Hydrate Review and Sucralfate Hydrate Label ), LEVOFLOXACIN HYDORATE (View Levofloxacin Hydorate Review and Levofloxacin Hydorate Label ), UREA (Optimal Dose) (View Urea Review and Urea Label ), KETOPROFEN (Optimal Sheet) (View Ketoprofen Review and Ketoprofen Label ), PANTETHINE (View Pantethine Review and Pantethine Label ), COTRIM (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

6919106-8 | Angina Pectoris, Atrial Fibrillation
Patient was taking Lenalidomide (View Usage). After Lenalidomide was administered, patient had the following side effects: angina pectoris, atrial fibrillation (What is atrial fibrillation?) on Jul 30, 2010 from SPAIN Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), prophylaxis, hypertension and. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), HYDROCHLOROTHIAZIDE (300/25 Mg) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6917381-7 | Acute Myocardial Infarction, Anaemia, Bacteraemia, Haematoma, Respiratory Failure, Septic Shock, Thrombocytopenia
Adverse event was reported on Jul 23, 2010 by a Male patient taking Lenalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), prophylaxis, coronary artery disease (What is coronary artery disease?), hypertension and. Location: CANADA , weighting 149.0 lb, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, anaemia, bacteraemia, haematoma, respiratory failure, septic shock, thrombocytopenia. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6917374-X | Leukaemia, Myelodysplastic Syndrome Transformation
on Mar 11, 2009 Female patient from ISRAEL , weighting 123.5 lb, was diagnosed with nausea (What is nausea?) and was treated with Lenalidomide (View Usage). Patient had the following side effects: leukaemia, myelodysplastic syndrome transformation. Lenalidomide dosage: . During the same period patient was treated with METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), CYTOSAR U (View Cytosar-u Review and Cytosar-u Label ), PROSCAR (View Proscar Review and Proscar Label ).

6916401-3 |
on Aug 03, 2010 Male patient from CANADA , weighting 192.5 lb, was diagnosed with oedema peripheral, constipation (What is constipation?), dyslipidaemia and was treated with Lenalidomide (View Usage). . Lenalidomide dosage: . During the same period patient was treated with CALCIUM AND VIT D (View Calcium And Vit D Review and Calcium And Vit D Label ), OMEGA 3 ACID ETHYL ESTERS (400-200mg) (View Omega-3-acid Ethyl Esters Review and Omega-3-acid Ethyl Esters Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), LASIX (View Lasix Review and Lasix Label ), COLACE (View Colace Review and Colace Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6915924-0 | Cytomegalovirus Infection, Herpes Ophthalmic, Leukopenia, Neutropenia, Ocular Vasculitis, Thrombocytopenia
Patient was taking Lenalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus infection (What is cytomegalovirus infection?), herpes ophthalmic, leukopenia, neutropenia, ocular vasculitis, thrombocytopenia on Jul 21, 2010 from FRANCE Additional patient health information: Male patient , weighting 125.7 lb, was diagnosed with t-cell lymphoma, eye infection (What is eye infection?) and. Lenalidomide dosage: . During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

6915200-6 | Ill-defined Disorder, Oedema Peripheral, Pleural Effusion, Ventricular Tachycardia
Adverse event was reported on Aug 05, 2010 by a Male patient taking Lenalidomide (View Usage) (Dosage: 10 Mg Every Day Po) . Location: UNITED STATES , 61 years of age, Patient had the following side effects: ill-defined disorder, oedema peripheral, pleural effusion, ventricular tachycardia. Patient was hospitalized.

6911522-3 | Anoxia, Aphasia, Atrial Fibrillation, Dehydration, Hypotension, Pancytopenia, Renal Injury, Sepsis, Tachycardia
on Jul 27, 2010 Male patient from UNITED STATES , weighting 218.0 lb, was diagnosed with prostate cancer (What is prostate cancer?), depression (What is depression?), hypertension and was treated with Lenalidomide (View Usage). After Lenalidomide was administered, patient had the following side effects: anoxia, aphasia (What is aphasia?), atrial fibrillation (What is atrial fibrillation?), dehydration, hypotension, pancytopenia, renal injury, sepsis (What is sepsis?), tachycardia. Lenalidomide dosage: . During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6910902-X | Acute Myeloid Leukaemia, Myelodysplastic Syndrome Transformation
on Aug 02, 2010 Female patient from FRANCE , weighting 154.3 lb, was treated with Lenalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, myelodysplastic syndrome transformation. Lenalidomide dosage: . During the same period patient was treated with VIDAZA (View Vidaza Review and Vidaza Label ).

6910822-0 | Colitis Ischaemic, Intestinal Ischaemia, Necrotising Colitis, Septic Shock
Patient was taking Lenalidomide (View Usage). Patient had the following side effects: colitis ischaemic, intestinal ischaemia, necrotising colitis, septic shock on Jun 15, 2010 from FRANCE Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), dyspepsia, thrombosis prophylaxis, pain prophylaxis and. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), KLAMATH (View Klamath Review and Klamath Label ), DESNODIUM (View Desnodium Review and Desnodium Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), LYTOS (View Lytos Review and Lytos Label ), ORACILLINE (View Oracilline Review and Oracilline Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

6909036-X | Acute Myocardial Infarction, Anaemia, Bacteraemia, Haematoma, Respiratory Failure, Septic Shock, Thrombocytopenia
Adverse event was reported on Jul 23, 2010 by a Male patient taking Lenalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), prophylaxis, coronary artery disease (What is coronary artery disease?), hypertension and. Location: CANADA , weighting 149.0 lb, After Lenalidomide was administered, patient had the following side effects: acute myocardial infarction, anaemia, bacteraemia, haematoma, respiratory failure, septic shock, thrombocytopenia. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6908862-0 | Disease Progression
on Jul 30, 2010 Female patient from FRANCE , weighting 114.6 lb, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Lenalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression. Lenalidomide dosage: . During the same period patient was treated with BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), PHLEBOGEL (View Phlebogel Review and Phlebogel Label ), XALATAN (View Xalatan Review and Xalatan Label ), RISEDRONATE SODIUM (View Risedronate Sodium Review and Risedronate Sodium Label ), CALCIUM CARBONATE W/COLECALCIFEROL (View Calcium Carbonate W/colecalciferol Review and Calcium Carbonate W/colecalciferol Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6902132-2 | Leukopenia
on Aug 02, 2010 Male patient from UNITED STATES , 84 years of age, weighting 130.0 lb, was treated with Lenalidomide (View Usage). Patient had the following side effects: leukopenia. Lenalidomide dosage: 20 Mg Every Day Po.

6901011-4 | Deafness Bilateral
Patient was taking Lenalidomide (View Usage). After Lenalidomide was administered, patient had the following side effects: deafness bilateral on Jul 15, 2010 from FRANCE Additional patient health information: Male patient , weighting 111.3 lb, was diagnosed with mantle cell lymphoma, phlebitis, anaemia and. Lenalidomide dosage: . During the same period patient was treated with RED BLOOD CELL TRANSFUSION (View Red Blood Cell Transfusion Review and Red Blood Cell Transfusion Label ), INNOHEP (View Innohep Review and Innohep Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ).

6900732-7 | Pulmonary Embolism
Adverse event was reported on Jul 27, 2010 by a Male patient taking Lenalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), prophylaxis, hypertension, nausea (What is nausea?), pain (What is pain?) and. Location: PORTUGAL , weighting 147.7 lb, Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LOSARTAN (View Losartan Review and Losartan Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), MICOSTATIN (View Micostatin Review and Micostatin Label ), PALMIDRONATE (View Palmidronate Review and Palmidronate Label ). Patient was hospitalized.

6900622-X | Multi-organ Failure, Septic Shock
on Jul 27, 2010 Male patient from POLAND , weighting 196.2 lb, was diagnosed with mantle cell lymphoma, disease progression and was treated with Lenalidomide (View Usage). Patient had the following side effects: multi-organ failure, septic shock. Lenalidomide dosage: . During the same period patient was treated with TAZOBACTAM (View Tazobactam Review and Tazobactam Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6899852-5 |
on Jul 26, 2010 Male patient from CANADA , weighting 192.5 lb, was diagnosed with oedema peripheral, constipation (What is constipation?), dyslipidaemia and was treated with Lenalidomide (View Usage). . Lenalidomide dosage: . During the same period patient was treated with CALCIUM AND VIT D (View Calcium And Vit D Review and Calcium And Vit D Label ), OMEGA 3 ACID ETHYL ESTERS (400-200mg) (View Omega-3-acid Ethyl Esters Review and Omega-3-acid Ethyl Esters Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), LASIX (View Lasix Review and Lasix Label ), COLACE (View Colace Review and Colace Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6882959-6 | Acute Coronary Syndrome, Atrial Fibrillation
Patient was taking Lenalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, atrial fibrillation (What is atrial fibrillation?) on Jul 20, 2010 from SPAIN Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6880840-X | Gastric Cancer
Adverse event was reported on Jul 17, 2010 by a Male patient taking Lenalidomide (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), cholecystitis, pneumonia (What is pneumonia?), dry skin, constipation (What is constipation?) and. Location: JAPAN , weighting 147.3 lb, Patient had the following side effects: gastric cancer. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ANTIBIOTIC (View Antibiotic Review and Antibiotic Label ), SUCRALFATE HYDRATE (View Sucralfate Hydrate Review and Sucralfate Hydrate Label ), LEVOFLOXACIN HYDORATE (View Levofloxacin Hydorate Review and Levofloxacin Hydorate Label ), UREA (Optimal Dose) (View Urea Review and Urea Label ), KETOPROFEN (Optimal Sheet) (View Ketoprofen Review and Ketoprofen Label ), PANTETHINE (View Pantethine Review and Pantethine Label ), COTRIM (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

6879924-1 | Acute Myeloid Leukaemia
on Jul 22, 2010 Female patient from FRANCE , weighting 114.6 lb, was treated with Lenalidomide (View Usage). After Lenalidomide was administered, patient had the following side effects: acute myeloid leukaemia. Lenalidomide dosage: .

6879604-2 | Acute Myocardial Infarction, Anaemia, Aspiration, Atelectasis, Bacteraemia, Cardiac Arrest, Escherichia Bacteraemia, Haematoma, Immune System Disorder
on Jul 23, 2010 Male patient from CANADA , weighting 149.0 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), prophylaxis, coronary artery disease (What is coronary artery disease?), hypertension and was treated with Lenalidomide (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, anaemia, aspiration, atelectasis, bacteraemia, cardiac arrest (What is cardiac arrest?), escherichia bacteraemia, haematoma, immune system disorder. Lenalidomide dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6876104-0 | Anaemia, Deafness Bilateral, Otorrhoea, Phlebitis, Pneumonia Streptococcal, Weight Decreased
Patient was taking Lenalidomide (View Usage). Patient had the following side effects: anaemia, deafness bilateral, otorrhoea, phlebitis, pneumonia streptococcal, weight decreased on Jul 15, 2010 from FRANCE Additional patient health information: Male patient , weighting 111.3 lb, was diagnosed with mantle cell lymphoma, phlebitis, anaemia and. Lenalidomide dosage: . During the same period patient was treated with RED BLOOD CELL TRANSFUSION (View Red Blood Cell Transfusion Review and Red Blood Cell Transfusion Label ), INNOHEP (View Innohep Review and Innohep Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ).